JPMorgan Chase & Co. Reiterates €26.90 Price Target for AXA (EPA:CS)
A number of other analysts have also weighed in on the company. Royal Bank of Canada set a €29.50 ($34.30) price objective on AXA and gave the company a buy rating in a research note on Wednesday, July 31st. Morgan Stanley set a €26.70 ($31.05) price objective on AXA and gave the company a buy rating in a research note on Tuesday, August 6th. Barclays reissued a neutral rating on shares of AXA in a research note on Wednesday, September 11th. UBS Group set a €22.00 ($25.58) price objective on AXA and gave the company a neutral rating in a research note on Monday, September 9th. Finally, HSBC set a €30.70 ($35.70) price objective on AXA and gave the company a neutral rating in a research note on Monday, June 3rd. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock has an average rating of Buy and an average target price of €26.64 ($30.98).
EPA:CS opened at €22.64 ($26.32) on Monday. AXA has a fifty-two week low of €22.13 ($25.73) and a fifty-two week high of €27.69 ($32.20). The company’s 50 day moving average is €21.92.
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.